[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350864-105":59,"doc-detail-350864-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-ranbp3l-in-pan-cancer-with-its-significance-in-hepatocellular-carcinoma","The Role of RANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma","","RAN binding protein 3-like (RANBP3L) is investigated for its diagnostic and prognostic relevance across pan-cancer, with focused evaluation in liver hepatocellular carcinoma (LIHC). TCGA-based analysis compares RANBP3L expression across 33 cancer types and links it to overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI). TIMER2.0 and CIBERSORT explore associations with immune infiltration, while LIHC patient tissues support validation using immunohistochemistry, qRT-PCR, and western blotting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-ranbp3l-in-pan-cancer-with-its-significance-in-hepatocellular-carcinoma/350864/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-ranbp3l-in-pan-cancer-with-its-significance-in-hepatocellular-carcinoma/350864.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on RANBP3L?","Question",{"text":112,"@type":113},"The study assesses the expression, diagnostic value, and prognostic significance of RANBP3L across pan-cancer, with special emphasis on hepatocellular carcinoma (LIHC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancer datasets and survival metrics are used to evaluate prognosis?",{"text":117,"@type":113},"RANBP3L expression is analyzed using TCGA for 33 cancer types, and prognosis is assessed using overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI).",{"name":119,"@type":110,"acceptedAnswer":120},"How is the relationship between RANBP3L and the immune microenvironment explored?",{"text":121,"@type":113},"Immune cell correlations are analyzed using TIMER2.0 and CIBERSORT, followed by LIHC tissue experiments to evaluate RANBP3L-related diagnostic and prognostic performance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350864,1790183843,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nThe Role ofRANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma  \nBeini Cen1  | Jie Li2  | Chao Wang2   \n1Zhejiang Key Laboratory of Zero Magnetic Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China | 2Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Westlake University, Hangzhou, China  \nCorrespondence: Chao Wang ([skqweasd1080@zju.edu.cn](skqweasd1080@zju.edu.cn))  \nReceived: 20 February 2025 | Revised: 18 August 2025 | Accepted: 15 December 2025  \nKeywords: biomarkers | liver hepatocellular carcinoma | RANBP3L | TCGA  \nABSTRACT  \nBackground: RAN binding protein 3-like (RANBP3L), a member of the Ran-binding protein family, has been linked to various cellular functions, but the role in cancer remains underexplored. In this research, we assessed the diagnostic and prognostic value of RANBP3L in pan-cancer, especially in liver hepatocellular carcinoma (LIHC) .  \nAims: This study aimed to explore the pan-cancer expression, prognostic value, and immune-related roles of RANBP3L, especially emphasis on validating its diagnostic and prognostic significance in hepatocellular carcinoma.  \nMethods: We analyzed RANBP3L expression of 33 cancer types from TCGA data and assessed its relationship with overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) . We used TIMER2.0 and CIBERSORT to explore the correlation between RANBP3L expression and immune cells. We conducted immunohistochemistry, qRT-PCR, and western blotting by using tissue samples from LIHC patients to assess the RANBP3L's diagnostic and prognostic value of LIHC. Results: In 18 different cancers, RANBP3L expression was found to be lower in tumor tissues compared to normal tissues, including LIHC. Lower RANBP3L expression was related to shorter OS, DSS, and PFI in LIHC. ROC analysis and the nomogram model based on RANBP3L expression demonstrated high predictive accuracy for patient diagnosis and survival. Moreover, immune infiltration analysis showed that RANBP3L was related to various immune cells and impacted prognosis. Furthermore, analysis of LIHC patient tissues found that higher RANBP3L expression was related to better tumor-free survival and OS. Conclusion: RANBP3L plays a crucial role in LIHC. Not only does its expression level correlate with patient survival, but it also plays an important role in immune modulation. RANBP3L presents a promising candidate for future therapeutic strategies anda biomarker for LIHC.  \n1 | Introduction  \nCancer is an important global health challenge, with rising incidence and mortality rates each year [1] . Among those prevalent cancers, liver hepatocellular carcinoma (LIHC) is particularly associated with high mortality rates worldwide [2] . Despite ongoing advancements in cancer diagnosis and treatment, the five-year overall survival (OS) rates for many  \ncancers remain low, highlighting the need for more effective therapeutic strategies [3] . While substantial progress has been made in utilizing cancer biomarkers for diagnosis and prognosis in certain cancers [4], the lack of effective biomarkers for liver and other cancers remains a significant barrier, given the need for innovative diagnostic and therapeutic methods to improve patient outcomes and offer new avenues for treatment [5] .  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2026; 9:e70440 1 of 10  \n[https://doi.org/10.1002/cnr2.70440](https://doi.org/10.1002/cnr2.70440)  \nRAN binding protein 3 like (RANBP3L) is from the family of Ran-binding proteins, which featured the presence of ","cbCaisCqbQtU1cw6","https://ap.wps.com/l/cbCaisCqbQtU1cw6","pdf",9420629,"English","# Abstract\n# Introduction\n# Methods\n## Database-Driven Analysis","[{\"question\":\"What is the main focus of this study on RANBP3L?\",\"answer\":\"The study assesses the expression, diagnostic value, and prognostic significance of RANBP3L across pan-cancer, with special emphasis on hepatocellular carcinoma (LIHC).\"},{\"question\":\"Which cancer datasets and survival metrics are used to evaluate prognosis?\",\"answer\":\"RANBP3L expression is analyzed using TCGA for 33 cancer types, and prognosis is assessed using overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI).\"},{\"question\":\"How is the relationship between RANBP3L and the immune microenvironment explored?\",\"answer\":\"Immune cell correlations are analyzed using TIMER2.0 and CIBERSORT, followed by LIHC tissue experiments to evaluate RANBP3L-related diagnostic and prognostic performance.\"}]","The Role of RANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma | PDF",1790091596,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/358695b212342e2e3f1a2ec7d7120065.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d307f0e7bf51cce2a326900719ddfc51.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b427a5ec79bb846c034402abf8312f10.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e46df3f6564c7dc05322e7b946cc551c.webp",980,1287]